Anavo Therapeutics Strengthens Management Team
LEIDEN, The Netherlands & HEIDELBERG, Germany--(BUSINESS WIRE)--Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase biology, announced today an EUR 8.5 million seed round extension, adding MRL Ventures Fund as a new investor. All existing investors, M Ventures, INKEF, Taiho Ventures, and Bioqube Ventures, participated in the extension, bringing the total seed round to EUR 28 million.
Mercy Ships, the global healthcare charity that provides free medical services to the world’s least advantaged peoples through a fleet of first-class hospital ships, announced today that it has appointed Gert van de Weerdhof as Interim Chief Executive Officer (CEO) to replace current Mercy Ships CEO, Tom Stogner, who retires June 25, 2021.